The association between urinary lead concentration and the likelihood of kidney stones in US adults: a population-based study

被引:0
作者
Liang, Dan [1 ]
Liu, Chang [2 ]
Yang, Mei [1 ]
机构
[1] Peoples Hosp Chongqing Liang Jiang New Area, Dept Endocrine, Chongqing, Peoples R China
[2] Nankai Univ, Sch Med, Tianjin, Peoples R China
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
Urinary lead; Kidney stones; NHANES; Cross-sectional study; UNITED-STATES; ACID LOAD; CALCIUM; PREVALENCE; EXPOSURE; RISK; RECEPTOR; CADMIUM;
D O I
10.1038/s41598-025-86086-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The negative effects of lead exposure on human health have attracted widespread attention. Our present study focused on assessing the relationship between urinary lead levels (ULL) and the risk of kidney stones in US adults. We used data from NHANES 2007-2018 for this cross-sectional study, where participants had complete data on ULL and kidney stones. The correlation between ULL and kidney stones was explored by weighted multiple logistic regression analysis. In addition, we also performed subgroup analysis and interaction tests. A total of 8325 subjects were included, and the prevalence of kidney stones was 9.90%. In the fully adjusted model, we observed a positive association between ULL and the risk of kidney stones (OR:1.07, 95% CI: 1.01-1.14, p = 0.03). Participants in the highest quartile of ULL had a 64% higher risk of kidney stones than those in the lowest quartile of ULL (OR:1.64, 95% CI: 1.05-2.57, p = 0.03). Subgroup analysis and interaction test indicated that the association between ULL and the risk of kidney stones was similar in different population settings. The findings of this study indicate a positive correlation between urine lead concentration and the risk of kidney stones. The potential prognostic value of the urine lead concentration for kidney stone outcomes was another new area investigated in this study. However, further prospective clinical trials are needed to confirm the role of urine lead in the pathogenesis of kidney disease and to validate urine lead as a reliable predictor of kidney stone risk.
引用
收藏
页数:9
相关论文
共 54 条
[1]   Enhanced remedial effects for vitamin D3 and calcium co-supplementation against pre-existing lead nephrotoxicity in mice: The roles of renal calcium homeostatic molecules [J].
Almaimani, Riyad A. ;
Almasmoum, Hussain ;
Ghaith, Mazen M. ;
El-Boshy, Mohamed ;
Idris, Shakir ;
Ahmad, Jawwad ;
Abdelghany, Abdelghany H. ;
BaSalamah, Mohammad A. ;
Mahbub, Amani ;
Refaat, Bassem .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (02) :512-524
[2]  
Bai S, 2023, FOOD FUNCT, V14, P3220, DOI [10.1039/d2fo03993a, 10.1039/D2FO03993A]
[3]   Tea and coffee consumption and pathophysiology related to kidney stone formation: a systematic review [J].
Barghouthy, Yazeed ;
Corrales, Mariela ;
Doizi, Steeve ;
Somani, Bhaskar K. ;
Traxer, Olivier .
WORLD JOURNAL OF UROLOGY, 2021, 39 (07) :2417-2426
[4]   Low-level exposure to lead, cadmium and mercury, and histopathological findings in kidney biopsies [J].
Barregard, Lars ;
Sallsten, Gerd ;
Lundh, Thomas ;
Molne, Johan .
ENVIRONMENTAL RESEARCH, 2022, 211
[5]  
CDC, about us
[6]   Sensing Extracellular Calcium - An Insight into the Structure and Function of the Calcium-Sensing Receptor (CaSR) [J].
Chavez-Abiega, Sergei ;
Mos, Iris ;
Centeno, Patricia P. ;
Elajnaf, Taha ;
Schlattl, Wolfgang ;
Ward, Donald T. ;
Goedhart, Joachim ;
Kallay, Eniko .
CALCIUM SIGNALING, 2ND EDITION, 2020, 1131 :1031-1063
[7]   Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney Stones [J].
Chewcharat, Api ;
Thongprayoon, Charat ;
Vaughan, Lisa E. ;
Mehta, Ramila A. ;
Schulte, Phillip J. ;
O'Connor, Helen M. ;
Lieske, John C. ;
Taylor, Eric N. ;
Rule, Andrew D. .
MAYO CLINIC PROCEEDINGS, 2022, 97 (08) :1437-1448
[8]   Kidney stone disease [J].
Coe, FL ;
Evan, A ;
Worcester, E .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2598-2608
[9]   Idiopathic hypercalciuria and formation of calcium renal stones [J].
Coe, Fredric L. ;
Worcester, Elaine M. ;
Evan, Andrew P. .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (09) :519-533
[10]   Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD [J].
Coyne, D ;
Acharya, M ;
Qiu, P ;
Abboud, H ;
Batlle, D ;
Rosansky, S ;
Fadem, S ;
Levine, B ;
Williams, L ;
Andress, DL ;
Sprague, SM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (02) :263-276